Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
Abstract Introduction: Cannabis use disorder (CUD) is prevalent in ~2–5% of adults in the United States and is anticipated to…
Abstract Introduction: Cannabis use disorder (CUD) is prevalent in ~2–5% of adults in the United States and is anticipated to…
Abstract Cannabis is frequently used by people who self-medicate for the signs of mental health conditions. Attention-deficit/hyperactivity disorder (ADHD), a…
Abstract Inflammation is the response of the innate immune system to any type of injury. Although acute inflammation is critical…
Abstract (1) Background: Synthetic cannabinoids (SCs) are emerging drugs of abuse sold as ‘K2’, ‘K9’ or ‘Spice’. Evidence shows that…
Abstract Aim. Drug abuse and addiction are major public health concerns, with millions of people worldwide affected by the negative…
Abstract Background: Anxiety is a condition for which current treatments are often limited by adverse events (AEs). Components of medicinal…
Abstract Limited research examines changes in quantities of various forms of smoked/vaped cannabis among regular consumers, including emerging adults (EAs;…
Abstract Over the past decades, Colombia has suffered complex social problems related to illicit crops, including forced displacement, violence, and…
Abstract Neuropathic pain is a debilitating condition characterized by abnormal signaling within the nervous system, resulting in persistent and often…
Abstract Cannabidiol (CBD) has previously been shown to inhibit inflammatory cytokine production in both in vitro and in vivo studies…